维普期刊资源整合服务平台（V6.5）

25篇 您的检索式：作者名="Cook GB"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	Single and repeated dose pharmacokinetics of eplerenone, a selective aldosterone receptor blocker, in rats显示文摘	Cook CS Zhang L Ames GB	2003	Xenobiotica2003，33，3：	1
2	Membranoproliferativeglomerulonephritis type II ( densedeposit disease) : an update显示文摘	Appel GB Cook HT Hageman G	2005	J Am Soc Nephrol2005，16，5：	1
3	Treatment options and future prospects for the management of eyelid malignancies : an evidence-based update 显示文摘	Cook BE Bartley GB	2001	Ophthalmology2001，108，：	1
4	Epidemiologic characteristics and clinical course of patients with malignant eyelid tumors in an incidence cohort in Olmsted Country, Minnesota显示文摘	Cook BE Jr Bartley GB	1999	Ophthalmology1999，106，：	1
5	Treatment options and future pros- pects for the management of eyelid malignancies: an evidence- based update 显示文摘	Cook BE Jr Bartley GB	2001	Ophthalmology2001，108，11：	1
6	Treatment options and future prospects for the management of eyelid malignancies:an evidence-based update 显示文摘	Cook BE Jr Bartley GB	2001	Ophthalmology2001，108，11：	1
7	Standardized repor- ting of radionuclide myocardial perfusion and function 显示文摘	Tilkemeier PL Cooke CD Grossman GB	2009	J Nucl Cardiol2009，16，65：	1
8	Treatment options and future prospects for the management of eyelid malignancies:An evidence-based update 显示文摘	Cook BE Jr Bartley GB	2001	Ophthalmology2001，108，11：	1
9	Epidemiologic characteristics and clini- cal course of patients with malignant eyelid tumors in an inci- dence cohort in Olmsted County 显示文摘	Cook BE Jr Bartley GB	1999	Ophthalmology1999，105，4：	1
10	Treatment options and future prospects for the management of eyelid malignancies: an evidence-based update 显示文摘	Cook BE Bartley GB	2001	Ophthalmology2001，108，11：	1
11	Clinical utility of serum Her-2/neu testing on the Bayer Immuno 1 automated system in breast cancer 显示文摘	Cook GB Neaman IE Goldblatt JL	2001	Anticancer Res2001，21，2：	1
12	Clinical utility of serum Her -2/neu testing on the Bayer Immuno automated system in breast cancer显示文摘	Cook GB Neaman IE Goldblatt JL	2001	Anticancer Res2001，21，2：	1
13	Membranoproliferative Glomerulo-nephritis Type Ⅱ (Dense Deposit Diease); An Update显示文摘	Appel GB Cook HT Hageman G	2005	J Am Soc Nephrol2005，16，：	1
14	Ophthalmic abnormalities in patients with cutaneous T-cell lymphoma显示文摘	Cook BE Jr Bartley GB Pittelkow MR	1999	Ophthalmology1999，106，7：	1
15	The role of macrophage inflammatory protein-1 alpha/CCL3 in regulation of T cell mediated immunity to Cryptococcus neoformans infection显示文摘	Olszewski MA Huffnagle GB McDonald RA Lindell DM Moore BB Cook DN Toews GB	2000	J Immunol2000，165，11：	1
16	Clinical utility of serum Her2/neu testing on the Bayer Immuno1automated system in breast can-cer显示文摘	Cook GB Neaman IE Goldbliatt JL		0，，：	1
17	Treatment options and future prospects for the management of eyelid malignancies: an evidence-based update 显示文摘	Cook BE Jr Bartley GB	2001	Ophthalmology2001，108，11：	1
18	Clinical utility of serum HER2/ neu testing on the Bayer Immunoautomated system in breast cancer 显示文摘	Cook GB Neaman IE Goldblatt JL	2001	Anticancer Res2001，21，：	1
19	Membranopro life- rative glomerulonephritis type Ⅱ (dense deposit disease): an update 显示文摘	Appel GB Cook HT Hageman G	2005	J Am Soc Nephrol2005，16，5：	1
20	Membranoproliferative glomerulonephritis type Ⅱ (dense deposit disease):an update显示文摘	Appel GB Cook HT Hageman G		0，，：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示